Unity Biotechnology, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Unity Biotechnology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2023.
  • Unity Biotechnology, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $797K, a 53.3% decline year-over-year.
  • Unity Biotechnology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $4.46M, a 46.9% decline year-over-year.
  • Unity Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.42M, a 20.9% decline from 2022.
  • Unity Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9.38M, a 18.8% decline from 2021.
  • Unity Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.6M, a 16.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7.42M -$1.96M -20.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-15
2022 $9.38M -$2.17M -18.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-15
2021 $11.6M -$2.26M -16.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-04-15
2020 $13.8M +$2.96M +27.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-15
2019 $10.9M +$1.41M +14.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 $9.44M +$6.41M +211% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-23
2017 $3.03M +$2.81M +1254% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-11
2016 $224K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.